ARBLI Trademark

Trademark Overview

On Saturday, December 17, 2022, a trademark application was filed for ARBLI with the United States Patent and Trademark Office. The USPTO has given the ARBLI trademark a serial number of 97721921. The federal status of this trademark filing is REGISTERED as of Tuesday, February 24, 2026. This trademark is owned by Scienture Inc.. The ARBLI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and therapeutic pharmaceuticals for the treatment of central nervous system, cardiovascular system, and oncological diseases and disorders
arbli

General Information

Serial Number97721921
Word MarkARBLI
Filing DateSaturday, December 17, 2022
Status700 - REGISTERED
Status DateTuesday, February 24, 2026
Registration Number8152347
Registration DateTuesday, February 24, 2026
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 31, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations and therapeutic pharmaceuticals for the treatment of central nervous system, cardiovascular system, and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, January 14, 2023
Primary Code005
First Use Anywhere DateFriday, August 15, 2025
First Use In Commerce DateFriday, August 15, 2025

Trademark Owner History

Party NameSCIENTURE, LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressCOMMACK, NY 11725
US
Party NameSCIENTURE, LLC
Party Type21 - New Owner After Publication
Legal Entity Type16 - Limited Liability Company
AddressCOMMACK, NY 11725
US
Party NameScienture Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCommack, NY 11725
US
Party NameScienture Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressHauppauge, NY 11788
US

Trademark Events

Event DateEvent Description
Wednesday, December 21, 2022NEW APPLICATION ENTERED
Saturday, January 14, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 20, 2023ASSIGNED TO EXAMINER
Wednesday, September 20, 2023NON-FINAL ACTION WRITTEN
Wednesday, September 20, 2023NON-FINAL ACTION E-MAILED
Wednesday, September 20, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 20, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Monday, September 25, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 25, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, September 26, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, September 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 11, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 31, 2023PUBLISHED FOR OPPOSITION
Tuesday, October 31, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 26, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 21, 2024SOU TEAS EXTENSION RECEIVED
Friday, June 21, 2024SOU EXTENSION 1 FILED
Friday, June 21, 2024SOU EXTENSION 1 GRANTED
Friday, June 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 27, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, December 17, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, December 18, 2024SOU EXTENSION 2 FILED
Wednesday, December 18, 2024SOU EXTENSION 2 GRANTED
Monday, March 3, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 22, 2025SOU TEAS EXTENSION RECEIVED
Thursday, May 22, 2025SOU EXTENSION 3 FILED
Thursday, May 22, 2025SOU EXTENSION 3 GRANTED
Friday, May 23, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 20, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, August 20, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, August 20, 2025SOU EXTENSION 4 FILED
Tuesday, January 20, 2026SOU EXTENSION 4 GRANTED
Wednesday, August 20, 2025USE AMENDMENT FILED
Tuesday, January 20, 2026STATEMENT OF USE PROCESSING COMPLETE
Wednesday, January 21, 2026NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 5, 2026ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, February 5, 2026NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, February 24, 2026REGISTERED-PRINCIPAL REGISTER
Tuesday, February 24, 2026NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

arbli system cardiovascular oncological diseases disorders nervous central preparations therapeutic pharmaceuticals